相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank
Adriano Tonelli
International Journal of Chronic Obstructive Pulmonary Disease (2012)
Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo
Devipriya Subramaniyam et al.
INFLAMMATION RESEARCH (2010)
Augmentation Therapy for α1 Antitrypsin Deficiency: A Meta-Analysis
Kenneth R. Chapman et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
Augmentation Therapy in Alpha-1 Antitrypsin Deficiency
Robert A. Sandhaus
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
Rate of progression of lung function impairment in α1-antitrypsin deficiency
P. A. Dawkins et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency
A. Dirksen et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Small-molecule peptides inhibit Z α1-antitrypsin polymerization
Yi-Pin Chang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009
Jason D. Christie et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
Mark L. Brantly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency
David G. Parr et al.
RESPIRATORY RESEARCH (2009)
Intravenous human plasma-derived augmentation therapy in α1-antitrypsin deficiency:: From pharmacokinetic analysis to individualizing therapy
Nuria Padulles Zamora et al.
ANNALS OF PHARMACOTHERAPY (2008)
α1-Antitrypsin Augmentation Therapy for PI*MZ Heterozygotes A Cautionary Note
Robert A. Sandhaus et al.
CHEST (2008)
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)
H. A. Tanash et al.
THORAX (2008)
Modification of gene expression and increase in α1-Antitrypsin (α1-AT) secretion after homologous recombination in α1-AT-Deficient monocytes
Gillian L. McNab et al.
HUMAN GENE THERAPY (2007)
Small molecules block the polymerization of Z α1-antitrypsin and increase the clearance of intracellular aggregates
Meera Mallyat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA
Pedro E. Cruz et al.
LABORATORY INVESTIGATION (2007)
alpha one antitrypsin deficiency: From gene to treatment
Alice M. Wood et al.
RESPIRATION (2007)
alpha-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro
Izabela M. Nita et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics
D. Soy et al.
THORAX (2006)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 α1-antitrypsin (AAT) vector in AAT-deficient adults
Mark L. Brantly et al.
HUMAN GENE THERAPY (2006)
Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use
E. Karnaukhova et al.
AMINO ACIDS (2006)
Aralast:: A new α1-protease inhibitor for treatment of α-antitrypsin deficiency
SG Louie et al.
ANNALS OF PHARMACOTHERAPY (2005)
Antibody response to aerosolized transgenic human alpha1-antitrypsin
LT Spencer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A review of alpha-1 antitrypsin deficiency
J Ranes et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo
R Mahadeva et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Concentration-dependent effects of native and polymerised α1-antitrypsin on primary human monocytes, in vitro -: art. no. 11
R Aldonyte et al.
BMC CELL BIOLOGY (2004)
Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency
LT Spencer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
α1-Antitrypsin deficiency•2:: Genetic aspects of α1-antitrypsin deficiency:: phenotypes and genetic modifiers of emphysema risk
DL DeMeo et al.
THORAX (2004)
Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes:: a meta-analysis
CP Hersh et al.
THORAX (2004)
Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin
S Janciauskiene et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
α1-Antitrypsin deficiency • 5:: Intravenous augmentation therapy:: current understanding
JK Stoller et al.
THORAX (2004)
Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with α-1-antitrypsin deficiency:: A preliminary study
JH Teckman
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
α1-Antitrypsin deficiency • 7:: Computed tomographic imaging in α1-antitrypsin deficiency
SB Shaker et al.
THORAX (2004)
α1-antitrypsin deficiency • 6:: New and emerging treatments for α1-anitrypsin deficiency
RA Sandhaus
THORAX (2004)
Recurrence of pulmonary emphysema in an α-1 proteinase inhibitor-deficient lung transplant recipient
H Mal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Major components of the direct medical costs of α1-antitrypsin deficiency
CD Mullins et al.
CHEST (2003)
Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia
C Greene et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Targeting a surface cavity of α1-antitrypsin to prevent conformational disease
H Parfrey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α1-antitrypsin
E Piitulainen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Cost-effectiveness analysis of augmentation therapy for severe α1-antitrypsin deficiency
TR Gildea et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Augmentation therapy with α1-antitrypsin -: Patterns of use and adverse events
JK Stoller et al.
CHEST (2003)
α1-Antitrypsin:: Not just an antiprotease -: Extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol
M Brantly
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Polyethylene glycol conjugation at Cys232 prolongs the half-life of α1 proteinase inhibitor
AM Cantin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Biochemical efficacy and safety of a new pooled human plasma α1-antitrypsin, respitin
JK Stoller et al.
CHEST (2002)
The effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiency
RA Stockley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Polymers of α1-antitrypsin are chemotactic for human neutrophils -: A new paradigm for the pathogenesis of emphysema
JS Parmar et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Change in lung function and morbidity from chronic obstructive pulmonary disease in α1-antitrypsin MZ heterozygotes:: A longitudinal study of the general population
M Dahl et al.
ANNALS OF INTERNAL MEDICINE (2002)
Cockroach allergen Bla g 2 -: Structure, function, and implications for allergic sensitization
A Pomés et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Mechanisms of disease -: Alpha1-antitrypsin deficiency -: A model for conformational diseases
RW Carrell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Recombinant adeno-associated virus gene therapy for cystic fibrosis and alpha(1)-antitrypsin deficiency
TR Flotte
CHEST (2002)
6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization - Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis
R Mahadeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline
LJ Dowson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects
A Churg et al.
LABORATORY INVESTIGATION (2001)
Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation
KC Meyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor
M Wencker et al.
CHEST (2001)
The direct medical costs of α-antitrypsin deficiency
CD Mullins et al.
CHEST (2001)
Expression and purification of functional human alpha-1-antitrypsin from cultured plant cells
JM Huang et al.
BIOTECHNOLOGY PROGRESS (2001)
Short-term supplementation therapy does not affect elastin degradation in severe α1-antitrypsin deficiency
DJ Gottlieb et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency - A new hypothesis with supporting data
J Lieberman
CHEST (2000)
Occupational exposure risks in individuals with PI*Z α1-antitrypsin deficiency
AS Mayer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography
K Soejima et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Should health-care systems pay for replacement therapy in patients with α1-antitrypsin deficiency?: A critical review and cost-effectiveness analysis
SA Alkins et al.
CHEST (2000)
Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z:: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency
JAJ Burrows et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Therapy for α1-antitrypsin deficiency -: Pharmacology and clinical recommendations
OA Minai et al.
BIODRUGS (2000)
Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ
N Seersholm et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency
MD Schluchter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
